Medical Litigation News and Research

RSS

Researchers find way to detect dangerous brain swelling in diabetic children

A rare swelling of the brain that is nonetheless the most common diabetes-related cause of death for children with the disease could be caught earlier — potentially saving lives — if practitioners learn to recognize key signs, researchers at the University of Florida report.

18 Aug 2004

System for monitoring and promoting human rights for people with disabilities around the world

Thanks to a $1.2 million grant from the Swedish International Development Cooperation Agency (SIDA), a York University-based group of international researchers are pressing ahead with plans to develop a system for monitoring and promoting human rights for people with disabilities around the world.

10 Aug 2004

Bristol-Myers Squibb final settlement with Securities and Exchange Commission (SEC)

Bristol-Myers Squibb has confirmed that it has reached a final settlement with the United States Securities and Exchange Commission (SEC), concluding an investigation concerning wholesaler inventory and accounting matters that began in April 2002.

5 Aug 2004

Court ruling favors State over pharmaceutical manufacturers

Nevada Attorney General Brian Sandoval yesterday announced that Washoe County District Court Judge Steven R. Kosach has issued an important ruling in Nevada's Average Wholesale Price (AWP) litigation against numerous pharmaceutical manufacturers including Abbott Labs, Baxter, Bristol-Myers Squibb, Dey, GlaxoSmithKline, and Pharmacia.

21 Jul 2004

Philip Morris to spend $1.25 billion over 12 years to combat the illegal trade in cigarettes worldwide

Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.

10 Jul 2004

States working to protect public health through fine particle standard

The United States Environmental Protection Agency (EPA) informed states and tribes of the status of counties as the country prepare to meet the nation's first fine particle (PM2.5) air quality standard.

29 Jun 2004

UK launch of The Institute of Medical Law

The University of Birmingham is continuing to lead the way in international research into medical-legal issues such as MMR, euthanasia and drug regulation with the launch of The Institute of Medical Law.

29 Jun 2004

Moves to cut the bureaucratic burden on hospitals

New moves to cut the bureaucratic burden on hospitals - freeing up more time for treating patients - were announced today by Health Minister Lord Warner.

23 Jun 2004

Lawsuit against 3 largest U.S. canned tuna companies for failing to warn about exposure to mercury

California Attorney General Bill Lockyer today filed a lawsuit against the nation's three largest canned tuna companies for failing to warn consumers that albacore and light tuna contain mercury, known by the state to cause reproductive harm and cancer.

22 Jun 2004

Mammograms, wider access, better technologies needed

Mammography has helped lower the death rate from breast cancer, but a new report by the Institute of Medicine says much could be done to improve breast cancer screening and save even more lives.

12 Jun 2004

New York State accuses GlaxoSmithKline of fraudulent behaviour

This week's editorial calls on GlaxoSmithKline (GSK) to make all its research on paroxetine (Seroxat/Paxil) publicly available. This follows the filing of last week's law suit by the state of New York against GSK: the state accuses the company of fraud

11 Jun 2004

Concealment by British American tobacco industries

Leading public-health scientists writing in this week's issue of THE LANCET are calling for changes in the management of British American Tobacco's (BATs) UK information depository. This follows a detailed investigation which has highlighted how public access to industry records has been hampered by tight surveillance and inadequate search facilities at the depository in Guildford, UK.

27 May 2004

Novogen granted Canadian patent for health supplements for the treatment of menopause symptoms

Pharmaceutical company, Novogen, has been granted patent coverage over its OTC products being sold in Canada. The patent covers the isoflavone composition of the products Promensil(TM), Rimostil(TM) and Trinovin(TM).

20 May 2004

BMA race discrimination case withdrawn by five applicants

The BMA has today agreed to settle five cases of race discrimination against the Association. The five applicants have withdrawn their claims against the BMA at the start of what could have been a four-week hearing in Manchester.

10 May 2004

Schering-Plough Corporation settles with $27 million to the State of Texas

Schering-Plough Corporation has announced that it has reached an agreement with the Attorney General's Office of the State of Texas to settle issues related to reimbursement by Texas' Medicaid program of albuterol sulfate solution and inhaler products.

3 May 2004

AGT Biosciences Limited and ChemGenex Therapeutics today announced merger agreement

AGT Biosciences Limited of Melbourne, Australia and privately held ChemGenex Therapeutics, Inc. of Menlo Park, California, today announced that they have signed a merger agreement. The cross-border merger creates a new, genomics-driven pharmaceutical company with leading edge capabilities for drug discovery and development, as well as two drug candidates in Phase II human trials for cancer.

28 Apr 2004